The sialic acid-binding immunoglobulin-like lectins (siglecs) represent a r
ecently defined distinct subset of the immunoglobulin superfamily. By using
the Src homology 2 (SH2)-domain-containing protein tyrosine phosphatase SH
P-1 as bait in a yeast two-hybrid screen, we have identified a new member o
f the mouse siglec family, mSiglec-E. The mSiglec-E cDNA encodes a protein
of 467 amino acids that contains three extracellular immunoglobulin-like do
mains, a transmembrane region and a cytoplasmic tail bearing two immunorece
ptor tyrosine-based inhibitory motifs (ITIMs). mSiglec-E is highly expresse
d in mouse spleen, a tissue rich in leucocytes. The ITIMs of mSiglec-E can
recruit SHP-1 and SHP-2, two inhibitory regulators of immunoreceptor signal
transduction. This suggests that the function of mSiglec-E is probably an
involvement in haematopoietic cells and the immune system as an inhibitory
receptor. When expressed in COS-7 cells, mSiglec-E was able to mediate sial
ic acid-dependent binding to human red blood cells, suggesting that mSiglec
-E may function through cell-cell interactions. In comparison with the know
n members of the siglec family, mSiglec-E exhibits a high degree of sequenc
e similarity to both human siglec-7 and siglec-9. The gene encoding mSiglec
-E is localized in the same chromosome as that encoding mouse CD33. Phyloge
netic analysis reveals that neither mouse mSiglec-E nor CD33 shows a clear
relationship with any human siglecs so far identified.